Decreased monocytic HLA-DR in patients with sepsis: Prediction of diagnosis, severity and prognosis
- PMID: 39550023
- DOI: 10.1016/j.clinbiochem.2024.110851
Decreased monocytic HLA-DR in patients with sepsis: Prediction of diagnosis, severity and prognosis
Abstract
Objective: Sepsis is characterized by high incidence and mortality rates, making early recognition and risk stratification critical for preventing delayed treatment and overtreatment. This study investigated the potential of monocytic (m) HLA-DR as a diagnostic and prognostic biomarker of sepsis.
Methods: In this prospective study, we collected blood in EDTA-anticoagulated tubes within 48 h from patients diagnosed with sepsis or infection and analyzed the percentage of mHLA-DR in peripheral blood mononuclear cells, C-reactive protein, and procalcitonin within 2 h of collection. We gathered clinical and laboratory data, including sex, age, and comorbidities, calculated the number of dysfunctional organs and sequential organ failure assessment (SOFA) score, and recorded the survival status of patients with sepsis on the 30th day after admission.
Results: mHLA-DR levels were lower in patients with sepsis (median 46.60 [interquartile range 23.86-66.51]%) than infection (75.44 [52.13-91.50]%). mHLA-DR could distinguish sepsis from infection with an area under the curve (AUC) of 0.724 (95 %CI 0.624-0.824). Decreased mHLA-DR levels have been found in septic patients with shock or secondary infections. mHLA-DR expression decreased with an increasing number of dysfunctional organs and higher SOFA score. In 30-day non-survivors, mHLA-DR levels were 26.94 (12.06-44.45)%, significantly lower than in survivors (55.20 [24.83-72.37]%). mHLA-DR predicted sepsis prognosis with an AUC of 0.750 (95 %CI 0.623-0.877). When the cut-off value was <52.29 %, the sensitivity and specificity of mHLA-DR for prognosis were 100 % and 52.83 %, respectively. The 30-day survival rate of septic patients with mHLA-DR ≥ 52.29 % was 6.798 (95 %CI 2.075-22.27) times higher than that of patients with mHLA-DR < 52.29 %.
Conclusion: mHLA-DR negatively correlates with the severity of sepsis and could be used as a diagnostic and prognostic biomarker for sepsis.
Keywords: Diagnosis; Infection; Monocytic HLA-DR; Prognosis; Sepsis; Severity.
Copyright © 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Predicting the Outcomes of Subjects With Severe Community-Acquired Pneumonia Using Monocyte Human Leukocyte Antigen-DR.Respir Care. 2015 Nov;60(11):1635-42. doi: 10.4187/respcare.03953. Epub 2015 Aug 11. Respir Care. 2015. PMID: 26264418
-
Ratio of serum procalcitonin to monocytic HLA-DR as a reliable parameter in prognosis prediction of sepsis.Clin Chim Acta. 2021 Aug;519:94-100. doi: 10.1016/j.cca.2021.04.011. Epub 2021 Apr 20. Clin Chim Acta. 2021. PMID: 33887265
-
Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes.Crit Care. 2020 Mar 20;24(1):110. doi: 10.1186/s13054-020-2830-x. Crit Care. 2020. PMID: 32192532 Free PMC article.
-
Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.Front Immunol. 2023 Feb 7;14:1130214. doi: 10.3389/fimmu.2023.1130214. eCollection 2023. Front Immunol. 2023. PMID: 36825018 Free PMC article. Review.
-
Poor Outcome Could Be Predicted by Lower Monocyte Human Leukocyte Antigen-DR Expression in Patients with Complicated Intra-Abdominal Infections: A Review.Surg Infect (Larchmt). 2020 Mar;21(2):77-80. doi: 10.1089/sur.2019.050. Epub 2019 Sep 4. Surg Infect (Larchmt). 2020. PMID: 31483200 Review.
Cited by
-
Sepsis-induced immunosuppression: mechanisms, biomarkers and immunotherapy.Front Immunol. 2025 Apr 29;16:1577105. doi: 10.3389/fimmu.2025.1577105. eCollection 2025. Front Immunol. 2025. PMID: 40364841 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials